Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inadequately Controlled Asthma”

55 trials

Showing 20 of 55 results

Large-scale testing (Phase 3)Ended earlyNCT03052517
What this trial is testing

Study of Safety of QAW039 in Patients With Asthma Inadequately Controlled on Standard-of-care Asthma Treatment

Who this might be right for
Asthma
Novartis Pharmaceuticals 2,538
Large-scale testing (Phase 3)Study completedNCT02161757
What this trial is testing

Evaluate the Efficacy and Safety of Tralokinumab in Adults and Adolescents With Uncontrolled Asthma

Who this might be right for
Uncontrolled Asthma
AstraZeneca 1,207
Large-scale testing (Phase 3)Study completedNCT02194699
What this trial is testing

Evaluate the Efficacy and Safety of Tralokinumab in Adults and Adolescents With Uncontrolled Asthma

Who this might be right for
Uncontrolled Asthma
AstraZeneca 856
Testing effectiveness (Phase 2)Study completedNCT01479595
What this trial is testing

Establish the Efficacy of QBX258 in Patients With Moderate to Severe Asthma

Who this might be right for
Asthma
Novartis Pharmaceuticals 65
Large-scale testing (Phase 3)Study completedNCT01328886
What this trial is testing

Long-term Safety, Tolerability and Efficacy of Omalizumab in Japanese Children

Who this might be right for
Allergic Asthma
Novartis Pharmaceuticals 38
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07250594
What this trial is testing

A Multi-dose Study on the Safety and Efficacy of Self-administered Intranasal AD17002 Treatment for Eosinophilic Asthma

Who this might be right for
Eosinophilic Asthma
Advagene Biopharma Co. Ltd. 126
Large-scale testing (Phase 3)Study completedNCT02563067
What this trial is testing

Study of Efficacy and Safety of QAW039 in Patients With Severe Asthma Inadequately Controlled With Standard of Care Asthma Treatment.

Who this might be right for
Asthma
Novartis Pharmaceuticals 877
Post-approval studies (Phase 4)Ended earlyNCT01912872
What this trial is testing

Study to Assess the Efficacy and Safety of Omalizumab Treatment on ICS Reduction for Severe IgE-mediated Asthma

Who this might be right for
Severe IgE-mediated Asthma
Novartis Pharmaceuticals 112
Testing effectiveness (Phase 2)Study completedNCT01437735
What this trial is testing

Dose Finding Study for QAW039 in Asthma

Who this might be right for
Asthma
Novartis Pharmaceuticals 1,043
Testing effectiveness (Phase 2)Study completedNCT02449473
What this trial is testing

Study to Evaluate Efficacy & Safety of Tralokinumab in Subjects With Asthma Inadequately Controlled on Corticosteroids

Who this might be right for
Asthma
AstraZeneca 79
Testing effectiveness (Phase 2)Ended earlyNCT01397162
What this trial is testing

Dose Finding Study on BI54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat® Inhaler in Asthmatic Patients Inadequately Controlled on Short-acting-beta-agonist (SABA) Therapy

Who this might be right for
Asthma
Boehringer Ingelheim 29
Large-scale testing (Phase 3)Study completedNCT04609878
What this trial is testing

Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (KALOS)

Who this might be right for
Asthma
AstraZeneca 2,274
Testing effectiveness (Phase 2)Study completedNCT03299686
What this trial is testing

Study to Assess the Efficacy and Safety of CJM112 in Patients With Inadequately Controlled Severe Asthma

Who this might be right for
Asthma
Novartis Pharmaceuticals 118
Testing effectiveness (Phase 2)Ended earlyNCT01902290
What this trial is testing

Study of Efficacy and Safety of Brodalumab Compared With Placebo in Adults With Inadequately Controlled Asthma With High Bronchodilator Reversibility

Who this might be right for
Asthma
Amgen 421
Large-scale testing (Phase 3)Study completedNCT02924688
What this trial is testing

A Phase III Parallel Group Study, Comparing the Efficacy, Safety and Tolerability of the Fixed Dose Combination (FDC) of Fluticasone Furoate+Umeclidinium Bromide+Vilanterol (FF/UMEC/VI) With the FDC of FF/VI in Subjects With Inadequately Controlled Asthma

Who this might be right for
Asthma
GlaxoSmithKline 2,436
Testing effectiveness (Phase 2)Study completedNCT01199289
What this trial is testing

Evaluate the Dosing of AMG 827 for Subjects With Inadequately Controlled Asthma

Who this might be right for
Asthma
Amgen 315
Large-scale testing (Phase 3)Study completedNCT05755906
What this trial is testing

A 12-week Study to Assess the Efficacy and Safety of Budesonide and Formoterol Fumarate Metered Dose Inhaler Relative to Budesonide Metered Dose Inhaler in Participants With Inadequately Controlled Asthma (LITHOS)

Who this might be right for
Asthma
AstraZeneca 374
Testing effectiveness (Phase 2)Study completedNCT02054130
What this trial is testing

Study to Evaluate the Efficacy and Safety of MEDI9929 (AMG 157) in Adult Subjects With Inadequately Controlled, Severe Asthma

Who this might be right for
Asthma
MedImmune LLC 584
Testing effectiveness (Phase 2)Active Not RecruitingNCT05851443
What this trial is testing

Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Inadequately Controlled Moderate to Severe Asthma

Who this might be right for
Moderate to Severe Asthma
Incyte Corporation 247
Large-scale testing (Phase 3)Study completedNCT00314574
What this trial is testing

Omalizumab (Xolair) in Subjects With Moderate to Severe Persistent Asthma (EXTRA)

Who this might be right for
Asthma
Genentech, Inc. 850
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation